Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 77

    1.

    Comparison of Monthly Ibandronate Versus Weekly Risedronate in Preference, Convenience, and Bone Turnover Markers in Korean Postmenopausal Osteoporotic Women.

    Chung YS, Lim SK, Chung HY, Lee IK, Park IH, Kim GS, Min YK, Kang MI, Chung DJ, Kim YK, Choi WH, Shong MH, Park JH, Byun DW, Yoon HK, Shin CS, Lee YS, Kwon NH.

    Calcif Tissue Int. 2009 Oct 9. [Epub ahead of print]PMID: 19816648 [PubMed - as supplied by publisher]Related articlesFree article

    2.

    Transcriptional corepressor SMILE recruits SIRT1 to inhibit nuclear receptor estrogen receptor-related receptor gamma transactivation.

    Xie YB, Park JH, Kim DK, Hwang JH, Oh S, Park SB, Shong M, Lee IK, Choi HS.

    J Biol Chem. 2009 Oct 16;284(42):28762-74. Epub 2009 Aug 18.PMID: 19690166 [PubMed - in process]Related articles

    3.

    Anti-obesity agents: a focused review on the structural classification of therapeutic entities.

    Oh S, Kim KS, Chung YS, Shong M, Park SB.

    Curr Top Med Chem. 2009;9(6):466-81.PMID: 19689361 [PubMed - in process]Related articles

    4.

    Fenofibrate differentially regulates plasminogen activator inhibitor-1 gene expression via adenosine monophosphate-activated protein kinase-dependent induction of orphan nuclear receptor small heterodimer partner.

    Chanda D, Lee CH, Kim YH, Noh JR, Kim DK, Park JH, Hwang JH, Lee MR, Jeong KH, Lee IK, Kweon GR, Shong M, Oh GT, Chiang JY, Choi HS.

    Hepatology. 2009 Sep;50(3):880-92.PMID: 19593819 [PubMed - indexed for MEDLINE]Related articles

    5.

    Peroxiredoxin II preserves cognitive function against age-linked hippocampal oxidative damage.

    Kim SU, Jin MH, Kim YS, Lee SH, Cho YS, Cho KJ, Lee KS, Kim YI, Kim GW, Kim JM, Lee TH, Lee YH, Shong M, Kim HC, Chang KT, Yu DY, Lee DS.

    Neurobiol Aging. 2009 Jul 2. [Epub ahead of print]PMID: 19577336 [PubMed - as supplied by publisher]Related articles

    6.

    The expression and role of serum response factor in papillary carcinoma of the thyroid.

    Kim HJ, Kim KR, Park HS, Jang KY, Chung MJ, Shong M, Moon WS.

    Int J Oncol. 2009 Jul;35(1):49-55.PMID: 19513551 [PubMed - indexed for MEDLINE]Related articles

    7.

    Association of LETM1 and MRPL36 contributes to the regulation of mitochondrial ATP production and necrotic cell death.

    Piao L, Li Y, Kim SJ, Byun HS, Huang SM, Hwang SK, Yang KJ, Park KA, Won M, Hong J, Hur GM, Seok JH, Shong M, Cho MH, Brazil DP, Hemmings BA, Park J.

    Cancer Res. 2009 Apr 15;69(8):3397-404. Epub 2009 Mar 24.PMID: 19318571 [PubMed - indexed for MEDLINE]Related articles

    8.

    Activation of NAD(P)H:quinone oxidoreductase 1 prevents arterial restenosis by suppressing vascular smooth muscle cell proliferation.

    Kim SY, Jeoung NH, Oh CJ, Choi YK, Lee HJ, Kim HJ, Kim JY, Hwang JH, Tadi S, Yim YH, Lee KU, Park KG, Huh S, Min KN, Jeong KH, Park MG, Kwak TH, Kweon GR, Inukai K, Shong M, Lee IK.

    Circ Res. 2009 Apr 10;104(7):842-50. Epub 2009 Feb 19.PMID: 19229058 [PubMed - indexed for MEDLINE]Related articles

    9.

    Clinical characteristics of primary thyroid lymphoma in Koreans.

    Hwang YC, Kim TY, Kim WB, Shong YK, Yi KH, Shong M, Jo YS, Kim WS, Chung JH.

    Endocr J. 2009 Jun;56(3):399-405. Epub 2009 Feb 18.PMID: 19225216 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Regulation of OPA1-mediated mitochondrial fusion by leucine zipper/EF-hand-containing transmembrane protein-1 plays a role in apoptosis.

    Piao L, Li Y, Kim SJ, Sohn KC, Yang KJ, Park KA, Byun HS, Won M, Hong J, Hur GM, Seok JH, Shong M, Sack R, Brazil DP, Hemmings BA, Park J.

    Cell Signal. 2009 May;21(5):767-77. Epub 2009 Jan 9.PMID: 19168126 [PubMed - indexed for MEDLINE]Related articles

    11.

    Pharmacological stimulation of NADH oxidation ameliorates obesity and related phenotypes in mice.

    Hwang JH, Kim DW, Jo EJ, Kim YK, Jo YS, Park JH, Yoo SK, Park MK, Kwak TH, Kho YL, Han J, Choi HS, Lee SH, Kim JM, Lee I, Kyung T, Jang C, Chung J, Kweon GR, Shong M.

    Diabetes. 2009 Apr;58(4):965-74. Epub 2009 Jan 9.PMID: 19136651 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Sodium arsenite induces orphan nuclear receptor SHP gene expression via AMP-activated protein kinase to inhibit gluconeogenic enzyme gene expression.

    Chanda D, Kim SJ, Lee IK, Shong M, Choi HS.

    Am J Physiol Endocrinol Metab. 2008 Aug;295(2):E368-79. Epub 2008 May 27.PMID: 18505831 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Modulatory role of phospholipase D in the activation of signal transducer and activator of transcription (STAT)-3 by thyroid oncogenic kinase RET/PTC.

    Kim YR, Byun HS, Won M, Park KA, Kim JM, Choi BL, Lee H, Hong JH, Park J, Seok JH, Kim DW, Shong M, Park SK, Hur GM.

    BMC Cancer. 2008 May 23;8:144.PMID: 18498667 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Diagnostic value of pyrosequencing for the BRAF V600E mutation in ultrasound-guided fine-needle aspiration biopsy samples of thyroid incidentalomas.

    Jo YS, Huang S, Kim YJ, Lee IS, Kim SS, Kim JR, Oh T, Moon Y, An S, Ro HK, Kim JM, Shong M.

    Clin Endocrinol (Oxf). 2009 Jan;70(1):139-44. Epub 2008 May 6.PMID: 18462259 [PubMed - indexed for MEDLINE]Related articles

    15.

    Orphan nuclear receptor SHP interacts with and represses hepatocyte nuclear factor-6 (HNF-6) transactivation.

    Lee YS, Kim DK, Kim YD, Park KC, Shong M, Seong HA, Ha HJ, Choi HS.

    Biochem J. 2008 Aug 1;413(3):559-69.PMID: 18459945 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Regulation of inhibitors of differentiation family proteins by thyroid-stimulating hormone in FRTL-5 thyroid cells.

    Jo YS, Hwang ES, Lee JH, Lee Y, Kim SY, Choi YS, Bai YS, Hong JH, Kim YJ, Lee IS, Rha SY, Ro HK, Shong M.

    J Korean Med Sci. 2008 Apr;23(2):262-9.PMID: 18437010 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Crif1 is a novel transcriptional coactivator of STAT3.

    Kwon MC, Koo BK, Moon JS, Kim YY, Park KC, Kim NS, Kwon MY, Kong MP, Yoon KJ, Im SK, Ghim J, Han YM, Jang SK, Shong M, Kong YY.

    EMBO J. 2008 Feb 20;27(4):642-53. Epub 2008 Jan 17.PMID: 18200042 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    EID-1 interacts with orphan nuclear receptor SF-1 and represses its transactivation.

    Park YY, Park KC, Shong M, Lee SJ, Lee YH, Choi HS.

    Mol Cells. 2007 Dec 31;24(3):372-7.PMID: 18182853 [PubMed - indexed for MEDLINE]Related articles

    19.

    Significance of the expression of major histocompatibility complex class II antigen, HLA-DR and -DQ, with recurrence of papillary thyroid cancer.

    Jo YS, Lee JC, Li S, Choi YS, Bai YS, Kim YJ, Lee IS, Rha SY, Ro HK, Kim JM, Shong M.

    Int J Cancer. 2008 Feb 15;122(4):785-90.PMID: 17957790 [PubMed - indexed for MEDLINE]Related articles

    20.

    CR6-interacting factor 1 represses the transactivation of androgen receptor by direct interaction.

    Suh JH, Shong M, Choi HS, Lee K.

    Mol Endocrinol. 2008 Jan;22(1):33-46. Epub 2007 Sep 20.PMID: 17885209 [PubMed - indexed for MEDLINE]Related articlesFree article

    21.

    Tumor suppressor LKB1 inhibits activation of signal transducer and activator of transcription 3 (STAT3) by thyroid oncogenic tyrosine kinase rearranged in transformation (RET)/papillary thyroid carcinoma (PTC).

    Kim DW, Chung HK, Park KC, Hwang JH, Jo YS, Chung J, Kalvakolanu DV, Resta N, Shong M.

    Mol Endocrinol. 2007 Dec;21(12):3039-49. Epub 2007 Aug 30.PMID: 17761947 [PubMed - indexed for MEDLINE]Related articlesFree article

    22.

    Energy-dependent regulation of cell structure by AMP-activated protein kinase.

    Lee JH, Koh H, Kim M, Kim Y, Lee SY, Karess RE, Lee SH, Shong M, Kim JM, Kim J, Chung J.

    Nature. 2007 Jun 21;447(7147):1017-20. Epub 2007 May 7.PMID: 17486097 [PubMed - indexed for MEDLINE]Related articles

    24.

    Orphan nuclear receptor small heterodimer partner inhibits transforming growth factor-beta signaling by repressing SMAD3 transactivation.

    Suh JH, Huang J, Park YY, Seong HA, Kim D, Shong M, Ha H, Lee IK, Lee K, Wang L, Choi HS.

    J Biol Chem. 2006 Dec 22;281(51):39169-78. Epub 2006 Oct 30.PMID: 17074765 [PubMed - indexed for MEDLINE]Related articlesFree article

    25.

    Reversible severe tricuspid regurgitation with right heart failure associated with thyrotoxicosis.

    Park JH, Shong M, Lee JH, Choi SW, Jeong JO, Seong IW.

    Thyroid. 2006 Aug;16(8):813-4. No abstract available. PMID: 16910887 [PubMed - indexed for MEDLINE]Related articles

    26.

    An orally administered multitarget tyrosine kinase inhibitor, SU11248, is a novel potent inhibitor of thyroid oncogenic RET/papillary thyroid cancer kinases.

    Kim DW, Jo YS, Jung HS, Chung HK, Song JH, Park KC, Park SH, Hwang JH, Rha SY, Kweon GR, Lee SJ, Jo KW, Shong M.

    J Clin Endocrinol Metab. 2006 Oct;91(10):4070-6. Epub 2006 Jul 18.PMID: 16849418 [PubMed - indexed for MEDLINE]Related articlesFree article

    27.

    Influence of the BRAF V600E mutation on expression of vascular endothelial growth factor in papillary thyroid cancer.

    Jo YS, Li S, Song JH, Kwon KH, Lee JC, Rha SY, Lee HJ, Sul JY, Kweon GR, Ro HK, Kim JM, Shong M.

    J Clin Endocrinol Metab. 2006 Sep;91(9):3667-70. Epub 2006 Jun 13.PMID: 16772349 [PubMed - indexed for MEDLINE]Related articlesFree article

    28.

    Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin.

    Park J, Lee SB, Lee S, Kim Y, Song S, Kim S, Bae E, Kim J, Shong M, Kim JM, Chung J.

    Nature. 2006 Jun 29;441(7097):1157-61. Epub 2006 May 3.PMID: 16672980 [PubMed - indexed for MEDLINE]Related articles

    29.

    Regulation of protein kinase B tyrosine phosphorylation by thyroid-specific oncogenic RET/PTC kinases.

    Jung HS, Kim DW, Jo YS, Chung HK, Song JH, Park JS, Park KC, Park SH, Hwang JH, Jo KW, Shong M.

    Mol Endocrinol. 2005 Nov;19(11):2748-59. Epub 2005 Jun 30.PMID: 15994200 [PubMed - indexed for MEDLINE]Related articlesFree article

    30.

    Characterization of neural cell types expressing peroxiredoxins in mouse brain.

    Jin MH, Lee YH, Kim JM, Sun HN, Moon EY, Shong MH, Kim SU, Lee SH, Lee TH, Yu DY, Lee DS.

    Neurosci Lett. 2005 Jun 24;381(3):252-7.PMID: 15896479 [PubMed - indexed for MEDLINE]Related articles

    31.

    Overexpression of ERp29 in the thyrocytes of FRTL-5 cells.

    Park S, You KH, Shong M, Goo TW, Yun EY, Kang SW, Kwon OY.

    Mol Biol Rep. 2005 Mar;32(1):7-13.PMID: 15865205 [PubMed - indexed for MEDLINE]Related articles

    32.

    Anti-inflammatory roles of retinoic acid in rat brain astrocytes: Suppression of interferon-gamma-induced JAK/STAT phosphorylation.

    Choi WH, Ji KA, Jeon SB, Yang MS, Kim H, Min KJ, Shong M, Jou I, Joe EH.

    Biochem Biophys Res Commun. 2005 Apr 1;329(1):125-31.PMID: 15721283 [PubMed - indexed for MEDLINE]Related articles

    33.

    p66Shc expression in proliferating thyroid cells is regulated by thyrotropin receptor signaling.

    Park YJ, Kim TY, Lee SH, Kim H, Kim SW, Shong M, Yoon YK, Cho BY, Park DJ.

    Endocrinology. 2005 May;146(5):2473-80. Epub 2005 Feb 10.PMID: 15705774 [PubMed - indexed for MEDLINE]Related articlesFree article

    34.

    CR6-interacting factor 1 interacts with orphan nuclear receptor Nur77 and inhibits its transactivation.

    Park KC, Song KH, Chung HK, Kim H, Kim DW, Song JH, Hwang ES, Jung HS, Park SH, Bae I, Lee IK, Choi HS, Shong M.

    Mol Endocrinol. 2005 Jan;19(1):12-24. Epub 2004 Sep 30.PMID: 15459248 [PubMed - indexed for MEDLINE]Related articlesFree article

    35.
    36.

    Orphan nuclear receptor small heterodimer partner represses hepatocyte nuclear factor 3/Foxa transactivation via inhibition of its DNA binding.

    Kim JY, Kim HJ, Kim KT, Park YY, Seong HA, Park KC, Lee IK, Ha H, Shong M, Park SC, Choi HS.

    Mol Endocrinol. 2004 Dec;18(12):2880-94. Epub 2004 Sep 9.PMID: 15358835 [PubMed - indexed for MEDLINE]Related articlesFree article

    37.

    Regulation of signal transducer and activator of transcription 1 (STAT1) and STAT1-dependent genes by RET/PTC (rearranged in transformation/papillary thyroid carcinoma) oncogenic tyrosine kinases.

    Hwang ES, Kim DW, Hwang JH, Jung HS, Suh JM, Park YJ, Chung HK, Song JH, Park KC, Park SH, Yun HJ, Kim JM, Shong M.

    Mol Endocrinol. 2004 Nov;18(11):2672-84. Epub 2004 Aug 5.PMID: 15297606 [PubMed - indexed for MEDLINE]Related articlesFree article

    38.

    The atypical orphan nuclear receptor DAX-1 interacts with orphan nuclear receptor Nur77 and represses its transactivation.

    Song KH, Park YY, Park KC, Hong CY, Park JH, Shong M, Lee K, Choi HS.

    Mol Endocrinol. 2004 Aug;18(8):1929-40. Epub 2004 May 20.PMID: 15155786 [PubMed - indexed for MEDLINE]Related articlesFree article

    39.

    Differential role of the loop region between helices H6 and H7 within the orphan nuclear receptors small heterodimer partner and DAX-1.

    Park YY, Kim HJ, Kim JY, Kim MY, Song KH, Cheol Park K, Yu KY, Shong M, Kim KH, Choi HS.

    Mol Endocrinol. 2004 May;18(5):1082-95. Epub 2004 Feb 12.PMID: 14963109 [PubMed - indexed for MEDLINE]Related articlesFree article

    40.

    Orphan nuclear receptor small heterodimer partner, a novel corepressor for a basic helix-loop-helix transcription factor BETA2/neuroD.

    Kim JY, Chu K, Kim HJ, Seong HA, Park KC, Sanyal S, Takeda J, Ha H, Shong M, Tsai MJ, Choi HS.

    Mol Endocrinol. 2004 Apr;18(4):776-90. Epub 2004 Jan 29.PMID: 14752053 [PubMed - indexed for MEDLINE]Related articlesFree article

    41.

    Gadd45gamma expression is reduced in anaplastic thyroid cancer and its reexpression results in apoptosis.

    Chung HK, Yi YW, Jung NC, Kim D, Suh JM, Kim H, Park KC, Kim DW, Hwang ES, Song JH, Ku BJ, Han HJ, Ro HK, Kim JM, Shong M.

    J Clin Endocrinol Metab. 2003 Aug;88(8):3913-20.PMID: 12915687 [PubMed - indexed for MEDLINE]Related articlesFree article

    42.

    Thyrotropin-mediated repression of class II trans-activator expression in thyroid cells: involvement of STAT3 and suppressor of cytokine signaling.

    Kim H, Suh JM, Hwang ES, Kim DW, Chung HK, Song JH, Hwang JH, Park KC, Ro HK, Jo EK, Chang JS, Lee TH, Lee MS, Kohn LD, Shong M.

    J Immunol. 2003 Jul 15;171(2):616-27.PMID: 12847226 [PubMed - indexed for MEDLINE]Related articlesFree article

    43.

    Identification of genes in thyrocytes regulated by unfolded protein response by using disulfide bond reducing agent of dithiothreitol.

    Park S, Hwang I, Shong M, Kwon OY.

    J Endocrinol Invest. 2003 Feb;26(2):132-7.PMID: 12739740 [PubMed - indexed for MEDLINE]Related articles

    44.

    RET/PTC (rearranged in transformation/papillary thyroid carcinomas) tyrosine kinase phosphorylates and activates phosphoinositide-dependent kinase 1 (PDK1): an alternative phosphatidylinositol 3-kinase-independent pathway to activate PDK1.

    Kim DW, Hwang JH, Suh JM, Kim H, Song JH, Hwang ES, Hwang IY, Park KC, Chung HK, Kim JM, Park J, Hemmings BA, Shong M.

    Mol Endocrinol. 2003 Jul;17(7):1382-94. Epub 2003 May 8.PMID: 12738763 [PubMed - indexed for MEDLINE]Related articlesFree article

    45.

    CR6-interacting factor 1 interacts with Gadd45 family proteins and modulates the cell cycle.

    Chung HK, Yi YW, Jung NC, Kim D, Suh JM, Kim H, Park KC, Song JH, Kim DW, Hwang ES, Yoon SH, Bae YS, Kim JM, Bae I, Shong M.

    J Biol Chem. 2003 Jul 25;278(30):28079-88. Epub 2003 Apr 25.PMID: 12716909 [PubMed - indexed for MEDLINE]Related articlesFree article

    46.

    Regulation of the phosphatidylinositol 3-kinase, Akt/protein kinase B, FRAP/mammalian target of rapamycin, and ribosomal S6 kinase 1 signaling pathways by thyroid-stimulating hormone (TSH) and stimulating type TSH receptor antibodies in the thyroid gland.

    Suh JM, Song JH, Kim DW, Kim H, Chung HK, Hwang JH, Kim JM, Hwang ES, Chung J, Han JH, Cho BY, Ro HK, Shong M.

    J Biol Chem. 2003 Jun 13;278(24):21960-71. Epub 2003 Mar 30.PMID: 12668683 [PubMed - indexed for MEDLINE]Related articlesFree article

    47.

    Activation of signal transducer and activator of transcription 3 by oncogenic RET/PTC (rearranged in transformation/papillary thyroid carcinoma) tyrosine kinase: roles in specific gene regulation and cellular transformation.

    Hwang JH, Kim DW, Suh JM, Kim H, Song JH, Hwang ES, Park KC, Chung HK, Kim JM, Lee TH, Yu DY, Shong M.

    Mol Endocrinol. 2003 Jun;17(6):1155-66. Epub 2003 Mar 13.PMID: 12637586 [PubMed - indexed for MEDLINE]Related articlesFree article

    48.

    Statin inhibits interferon-gamma-induced expression of intercellular adhesion molecule-1 (ICAM-1) in vascular endothelial and smooth muscle cells.

    Chung HK, Lee IK, Kang H, Suh JM, Kim H, Park KC, Kim DW, Kim YK, Ro HK, Shong M.

    Exp Mol Med. 2002 Dec 31;34(6):451-61.PMID: 12526087 [PubMed - indexed for MEDLINE]Related articlesFree article

    49.

    CXC chemokine receptor 4 expression and function in human anaplastic thyroid cancer cells.

    Hwang JH, Hwang JH, Chung HK, Kim DW, Hwang ES, Suh JM, Kim H, You KH, Kwon OY, Ro HK, Jo DY, Shong M.

    J Clin Endocrinol Metab. 2003 Jan;88(1):408-16.PMID: 12519884 [PubMed - indexed for MEDLINE]Related articlesFree article

    50.

    Involvement of the protein kinase C pathway in thyrotropin-induced STAT3 activation in FRTL-5 thyroid cells.

    Park YJ, Park ES, Kim MS, Kim TY, Lee HS, Lee S, Jang IS, Shong M, Park DJ, Cho BY.

    Mol Cell Endocrinol. 2002 Aug 30;194(1-2):77-84.PMID: 12242030 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...